잠시만 기다려 주세요. 로딩중입니다.

Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy

Clinical and Molecular Hepatology 2020년 26권 3호 p.251 ~ 260
Huang Chung-Feng, Yu Ming-Lung,
소속 상세정보
 ( Huang Chung-Feng ) - Kaohsiung Medical University Kaohsiung Medical University Hospital Department of Internal Medicine
 ( Yu Ming-Lung ) - Kaohsiung Medical University Kaohsiung Medical University Hospital Department of Internal Medicine

Abstract


The treatment of chronic hepatitis C (CHC) has been revolutionized in an era of all-oral direct-acting antivirals (DAAs) since 2014. Satisfactory treatment efficacy and tolerability can be provided by novel DAAs. Nevertheless, there are still some unmet needs and emerging issues in the treatment of CHC in the DAA era. Certain hard-to-cure populations are prone to have inferior treatment responses, including patients with severe liver decompensation, active hepatocellular carcinoma (HCC), and hepatitis C virus (HCV) genotype 3 (HCV-3) infection and those who experience multiple DAA treatment failures. Hepatitis B virus (HBV) reactivation during and after DAA treatment has raised concern regarding the use of prophylactic antivirals against HBV throughout DAA treatment. However, the standard strategy for the use of prophylactic antivirals is not uniform across regional guidelines. In the post-sustained virological response (SVR) period, HCC still occurs in a substantial proportion of patients. Due to the relatively short follow-up period, the net benefit of the achievement of an SVR by DAAs in the reduction of extrahepatic manifestations has not yet been determined. Attention must also be paid to HCV reinfection, particularly in high-risk populations. The most critical and unmet need for HCV elimination is the large gap in the HCV care cascade at the population level. To accomplish the World Health Organization (WHO)’s goal for HCV elimination by 2030, the expansion of access to HCV care requires a continuous effort to overcome practical and political challenges.

키워드

Hepatitis C virus; Direct-acting antivirals; Treatment

원문 및 링크아웃 정보

 

등재저널 정보